(Q43094927)

13 November 2017

1 reference

title

Interferon associated retinopathy (English)

1 reference

13 November 2017

Hayasaka S

1

1 reference

13 November 2017

Nagaki Y

series ordinal

2

1 reference

13 November 2017

Matsumoto M

series ordinal

3

1 reference

13 November 2017

Sato S

series ordinal

4

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

British Journal of Ophthalmology

13 November 2017

1 reference

13 November 2017

82

1 reference

13 November 2017

323-325

1 reference

13 November 2017

3

1 reference

Virus interference. I. The interferon

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722505

Local interferon alfa-2b for ocular cicatricial pemphigoid

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722505

Clinical characteristics of hepatitis C virus-associated retinopathy.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722505

Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722505

Regression of experimental iris neovascularization with systemic alpha-interferon.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722505

Inhibition of endothelial cell proliferation by gamma-interferon

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722505

Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanoma

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722505

Clinical toxicity of interferons in cancer patients: a review

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722505

Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722505

Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722505

Interferon-associated retinopathy

15 August 2018

1 reference

12 December 2020

[Interferon-induced retinal changes]

1 reference

12 December 2020

[Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis]

1 reference

12 December 2020

Recombinant leukocyte A interferon in Kaposi's sarcoma

1 reference

12 December 2020

Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma

1 reference

12 December 2020

Toxicity of intravitreal interferon

1 reference

12 December 2020

Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a

1 reference

12 December 2020

Oculomotor nerve paralysis induced by alpha II-interferon

1 reference

12 December 2020

Interferon alpha 2a for treatment of age-related macular degeneration

1 reference

12 December 2020

Identifiers

DOI

10.1136/BJO.82.3.323

1 reference

13 November 2017

1 reference

13 November 2017

1 reference